Financial reports
10-Q
2021 Q3
Quarterly report
4 Nov 21
10-Q
2021 Q2
Quarterly report
5 Aug 21
10-Q
2021 Q1
Quarterly report
6 May 21
10-K
2020 FY
Annual report
4 Mar 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
10-Q
2020 Q2
Quarterly report
6 Aug 20
10-Q
2020 Q1
Quarterly report
7 May 20
10-K
2019 FY
Annual report
5 Mar 20
10-Q
2019 Q3
Quarterly report
7 Nov 19
10-Q
2019 Q2
Quarterly report
5 Aug 19
Current reports
8-K
Sanofi completes acquisition of Kadmon
9 Nov 21
8-K
Submission of Matters to a Vote of Security Holders
5 Nov 21
8-K
Kadmon Provides Business Update and Reports Third Quarter 2021 Financial Results
4 Nov 21
8-K
Other Events
27 Oct 21
8-K
Other Events
21 Oct 21
8-K
Sanofi to acquire Kadmon to further strengthen growth of transplant business
8 Sep 21
8-K
Kadmon Provides Business Update and Reports Second Quarter 2021 Financial Results
5 Aug 21
8-K
Other Events
19 Jul 21
8-K
Submission of Matters to a Vote of Security Holders
12 May 21
8-K
Kadmon Provides Business Update and Reports First Quarter 2021 Financial Results
6 May 21
Registration and prospectus
15-12B
Securities registration termination
19 Nov 21
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Nov 21
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Nov 21
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Nov 21
POS AM
Prospectus update (post-effective amendment)
9 Nov 21
25-NSE
Exchange delisting
9 Nov 21
POS AM
Prospectus update (post-effective amendment)
9 Nov 21
S-8 POS
Registration of securities for employees (post-effective amendment)
9 Nov 21
S-8
Registration of securities for employees
5 Mar 21
8-A12B
Registration of securities on exchange
23 Oct 20
Proxies
DEFA14A
Additional proxy soliciting materials
27 Oct 21
DEFA14A
Additional proxy soliciting materials
21 Oct 21
DEFM14A
Proxy related to merger
4 Oct 21
PREM14A
Preliminary proxy related to merger
21 Sep 21
DEFA14A
Additional proxy soliciting materials
8 Sep 21
DEFA14A
Additional proxy soliciting materials
3 May 21
DEFA14A
Additional proxy soliciting materials
1 Apr 21
DEF 14A
Definitive proxy
1 Apr 21
DEFA14A
Additional proxy soliciting materials
2 Apr 20
DEF 14A
Definitive proxy
2 Apr 20
Other
EFFECT
Notice of effectiveness
16 Nov 21
EFFECT
Notice of effectiveness
16 Nov 21
CERT
Certification of approval for exchange listing
23 Oct 20
EFFECT
Notice of effectiveness
17 Jun 20
CORRESP
Correspondence with SEC
12 Jun 20
UPLOAD
Letter from SEC
12 Jun 20
EFFECT
Notice of effectiveness
25 Sep 19
CORRESP
Correspondence with SEC
20 Sep 19
UPLOAD
Letter from SEC
19 Sep 19
EFFECT
Notice of effectiveness
10 Jan 18
Ownership